270 related articles for article (PubMed ID: 29153995)
1. Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy.
Weldegiorgis M; de Zeeuw D; Li L; Parving HH; Hou FF; Remuzzi G; Greene T; Heerspink HJL
Am J Kidney Dis; 2018 Jan; 71(1):91-101. PubMed ID: 29153995
[TBL] [Abstract][Full Text] [Related]
2. Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT).
Lambers Heerspink HJ; Weldegiorgis M; Inker LA; Gansevoort R; Parving HH; Dwyer JP; Mondal H; Coresh J; Greene T; Levey AS; de Zeeuw D
Am J Kidney Dis; 2014 Feb; 63(2):244-50. PubMed ID: 24210590
[TBL] [Abstract][Full Text] [Related]
3. Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.
Brosnahan GM; Abebe KZ; Moore CG; Rahbari-Oskoui FF; Bae KT; Grantham JJ; Schrier RW; Braun WE; Chapman AB; Flessner MF; Harris PC; Hogan MC; Perrone RD; Miskulin DC; Steinman TI; Torres VE;
Am J Kidney Dis; 2018 May; 71(5):666-676. PubMed ID: 29306517
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal progression trajectory of GFR among patients with CKD.
Li L; Astor BC; Lewis J; Hu B; Appel LJ; Lipkowitz MS; Toto RD; Wang X; Wright JT; Greene TH
Am J Kidney Dis; 2012 Apr; 59(4):504-12. PubMed ID: 22284441
[TBL] [Abstract][Full Text] [Related]
5. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials.
Lambers Heerspink HJ; Tighiouart H; Sang Y; Ballew S; Mondal H; Matsushita K; Coresh J; Levey AS; Inker LA
Am J Kidney Dis; 2014 Dec; 64(6):860-6. PubMed ID: 25441439
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Estimated Glomerular Filtration Rate Decline Leading to End-Stage Renal Disease in Type 1 Diabetes.
Skupien J; Warram JH; Smiles AM; Stanton RC; Krolewski AS
Diabetes Care; 2016 Dec; 39(12):2262-2269. PubMed ID: 27647852
[TBL] [Abstract][Full Text] [Related]
7. The influence of sex on renal function decline in people with Type 2 diabetes.
de Hauteclocque A; Ragot S; Slaoui Y; Gand E; Miot A; Sosner P; Halimi JM; Zaoui P; Rigalleau V; Roussel R; Saulnier PJ; Hadjadj Samy S;
Diabet Med; 2014 Sep; 31(9):1121-8. PubMed ID: 24773061
[TBL] [Abstract][Full Text] [Related]
8. Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.
Fufaa GD; Weil EJ; Lemley KV; Knowler WC; Brosius FC; Yee B; Mauer M; Nelson RG
Clin J Am Soc Nephrol; 2016 Feb; 11(2):254-61. PubMed ID: 26792530
[TBL] [Abstract][Full Text] [Related]
9. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
[TBL] [Abstract][Full Text] [Related]
10. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
Fernández-Juárez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Lahera V; Casas L; Oliva J;
Clin J Am Soc Nephrol; 2013 Nov; 8(11):1870-6. PubMed ID: 24135218
[TBL] [Abstract][Full Text] [Related]
11. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function.
Gu L; Huang L; Wu H; Lou Q; Bian R
Diab Vasc Dis Res; 2017 May; 14(3):221-225. PubMed ID: 28183204
[TBL] [Abstract][Full Text] [Related]
12. GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials.
Inker LA; Lambers Heerspink HJ; Mondal H; Schmid CH; Tighiouart H; Noubary F; Coresh J; Greene T; Levey AS
Am J Kidney Dis; 2014 Dec; 64(6):848-59. PubMed ID: 25441438
[TBL] [Abstract][Full Text] [Related]
13. An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function.
Holtkamp FA; de Zeeuw D; Thomas MC; Cooper ME; de Graeff PA; Hillege HJ; Parving HH; Brenner BM; Shahinfar S; Lambers Heerspink HJ
Kidney Int; 2011 Aug; 80(3):282-7. PubMed ID: 21451458
[TBL] [Abstract][Full Text] [Related]
14. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease.
Skupien J; Warram JH; Smiles AM; Niewczas MA; Gohda T; Pezzolesi MG; Cantarovich D; Stanton R; Krolewski AS
Kidney Int; 2012 Sep; 82(5):589-97. PubMed ID: 22622493
[TBL] [Abstract][Full Text] [Related]
15. Estimating glomerular filtration rate: Performance of the CKD-EPI equation over time in patients with type 2 diabetes.
Wood AJ; Churilov L; Perera N; Thomas D; Poon A; MacIsaac RJ; Jerums G; Ekinci EI
J Diabetes Complications; 2016; 30(1):49-54. PubMed ID: 26597601
[TBL] [Abstract][Full Text] [Related]
16. C-Terminal Fragment of Agrin (CAF): A Novel Marker for Progression of Kidney Disease in Type 2 Diabetics.
Devetzis V; Daryadel A; Roumeliotis S; Theodoridis M; Wagner CA; Hettwer S; Huynh-Do U; Ploumis P; Arampatzis S
PLoS One; 2015; 10(12):e0143524. PubMed ID: 26630274
[TBL] [Abstract][Full Text] [Related]
17. Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.
Tanaka N; Babazono T; Takagi M; Yoshida N; Toya K; Nyumura I; Hanai K; Uchigata Y
Nephrology (Carlton); 2015 Aug; 20(8):531-8. PubMed ID: 25773273
[TBL] [Abstract][Full Text] [Related]
18. Rapid GFR decline is associated with renal hyperfiltration and impaired GFR in adults with Type 1 diabetes.
Bjornstad P; Cherney DZ; Snell-Bergeon JK; Pyle L; Rewers M; Johnson RJ; Maahs DM
Nephrol Dial Transplant; 2015 Oct; 30(10):1706-11. PubMed ID: 26050268
[TBL] [Abstract][Full Text] [Related]
19. Utility and validity of estimated GFR-based surrogate time-to-event end points in CKD: a simulation study.
Greene T; Teng CC; Inker LA; Redd A; Ying J; Woodward M; Coresh J; Levey AS
Am J Kidney Dis; 2014 Dec; 64(6):867-79. PubMed ID: 25441440
[TBL] [Abstract][Full Text] [Related]
20. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
Ivory SE; Packham DK; Reutens AT; Wolfe R; Rohde RD; Lewis J; Atkins RC;
Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
